The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Repetitive 18F‐fluorodeoxyglucose positron emission tomography in giant cell arteritis: A prospective study of 35 patients
Abstract
Objective: To study fluorodeoxyglucose (FDG) uptake in the different vascular beds and in the large joints of patients with giant cell arteritis (GCA) at diagnosis, during steroid treatment, and at relapse. Methods: All consecutive patients admitted to our department with a diagnosis of GCA underwent FDG–positron emission tomography (PET) scan before treatment with methylprednisolone was started. PET scans were repeated at 3 and 6 months, if the initial PET scans showed vascular FDG uptake. PET scans were scored at 7 different vascular areas and a total vascular score (TVS) was calculated, ranging from 0 to 21. Results: A total of 35 patients entered the study. At diagnosis, vascular FDG uptake was noted in 29 patients (83%), especially in the subclavian arteries (74%), but also in the aorta (>50%) and up to the femoral arteries (37%). TVS decreased from a mean ± SD score of 7.9 ± 5.5 at baseline to 2.4 ± 3.5 on repeat PET scan at 3 months (P < 0.0005), but did not further decrease at 6 months. The patients who relapsed had similar earlier decreases of TVS compared with those who did not relapse. FDG uptake in the shoulders at diagnosis correlated significantly with the presence of polymyalgia rheumatica (P = 0.005). Conclusion: FDG uptake in the large vessels is a sensitive marker for GCA, which can involve the larger thoracic, abdominal, and peripheral arteries. Polymyalgia rheumatica symptoms in patients with GCA correlate with (peri)synovitis of the shoulders. Relapses of GCA cannot be predicted by results of former PET scintigraphies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polymyalgia Rheumatica and Giant-Cell Arteritis
Salvarani, C., Cantini, F., Boiardi, L., & Hunder, G. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011913 · Cited by 1,352
Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes
Proven, A., Gabriel, S. E., Orces, C., O'Fallon, W. M., & Hunder, G. G. (2003) · Arthritis Care & Research · doi:10.1002/art.11388 · Cited by 612
Polymyalgia Rheumatica: A 10-Year Epidemiologic and Clinical Study
CHUANG, T.-Y., HUNDER, G. G., ILSTRUP, D. M., & KURLAND, L. T. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-5-672 · Cited by 518
HUSKISSON, E. C., & HART, F. D. (1987) · Joint Disease · doi:10.1016/b978-0-7236-0571-3.50187-7 · Cited by 436
Blockmans, D., Stroobants, S., Maes, A., & Mortelmans, L. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00424-6 · Cited by 347
Self-citationNew arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography.
Blockmans, D., Maes, A., Stroobants, S., Nuyts, J., Bormans, G., Knockaert, D., Bobbaers, H., & Mortelmans, L. (1999) · Rheumatology · doi:10.1093/rheumatology/38.5.444 · Cited by 221
Self-citationGlucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras.
Brack, A., Rittner, H. L., Younge, B. R., Kaltschmidt, C., Weyand, C. M., & Goronzy, J. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119477 · Cited by 140
Are polymyalgia rheumatica and giant cell arteritis the same disease?
Cantini, F., Niccoli, L., Storri, L., Nannini, C., Olivieri, I., Padula, A. A., Boiardi, L., & Salvarani, C. (2004) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2003.09.008 · Cited by 115
Fludeoxyglucose Positron Emission Tomography in the Diagnosis of Giant Cell Arteritis
Turlakow, A., Yeung, H. W. D., Pui, J. C., Macapinlac, H. A., Liebovitz, E., Rusch, V. W., Goy, A. H., & Larson, S. M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.7.1003 · Cited by 100
Cited by
Erbel (2014) · doi:10.1093/eurheartj/ehu281 · Cited by 4,451
Isselbacher, E. M., Preventza, O., Hamilton Black, J., Augoustides, J. G., Beck, A. W., Bolen, M. A., Braverman, A. C., Bray, B. E., Brown-Zimmerman, M. M., Chen, E. P., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001106 · Cited by 2,082
2018 Update of the EULAR recommendations for the management of large vessel vasculitis
Hellmich, B., Agueda, A., Monti, S., Buttgereit, F., de Boysson, H., Brouwer, E., Cassie, R., Cid, M. C., Dasgupta, B., Dejaco, C., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215672 · Cited by 1,200
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
Dejaco, C., Ramiro, S., Duftner, C., Besson, F. L., Bley, T. A., Blockmans, D., Brouwer, E., Cimmino, M. A., Clark, E., Dasgupta, B., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212649 · Cited by 963
Self-citationPolymyalgia rheumatica and giant-cell arteritis
Salvarani, C., Cantini, F., & Hunder, G. G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61077-6 · Cited by 767
Metadata
- Authors
- Blockmans, D., Ceuninck, L. D., Vanderschueren, S., Knockaert, D., Mortelmans, L., & Bobbaers, H.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2006-02-06
- Volume
- 55
- Issue
- 1
- Pages
- 131-137
- ISSN
- 0893-7524 (ISSN-L)
- 1529-0123
- OpenAlex
- W2017295541
- Cited by
- 628
- References
- 9
- FWCI
- 22.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.